ABSTRACT Marek's disease (MD), caused by Marek's disease virus (MDV), is a lymphoproliferative neoplastic disease of chickens and is characterized by MD lymphoma in multiple visceral organs of chicken. It causes great damage to poultry health. Recently, miRNA has been reported to be involved in Marek's disease lymphomagenesis. Our previous study showed that ggamiR-181a was downregulated in MDV-induced lymphoma, and its target gene, v-myb myeloblastosis viral oncogene homolog-like 1 (MYBL1), was predicted. In this study, the interaction between gga-miR-181a and MYBL1 was further verified by detecting protein expression levels of MYBL1 after transfecting miR-181a mimic into MD lymphoma cell line, MSB1. The result showed that protein level of MYBL1 was lower in gga-miR-181a mimic transfecting group than that in the negative control group at 96 h post transfection, which indicated that MYBL1 was a target gene of gga-miR-181a. Additionally, we found that the expression of MYBL1 was higher in MDV-infected samples than that in non-infected controls, which agreed with the proposition that miRNA showed a negatively correlated expression pattern with its target gene. We observed the inhibitory effect of gga-miR-181a on MSB1 cell proliferation. Collectively, the aberrant expression of gga-miR-181a and MYBL1 in MD lymphoma suggested that they might be involved in MD tumor transformation and played important roles.
INTRODUCTION
Marek's disease (MD) is a highly contagious, avian T-cell lymphoid neoplasia disease, which is caused by Marek's disease virus (MDV), a highly oncogenic cellassociated alpha-herpesvirus. Generally, host-MDV interaction undergoes 4 phases, including cytolysis (3 to 6 days post infection), latency (7 to 10 days post infection), late cytolysis (10 to 14 days post infection in susceptible chickens), and neoplastic lymphoma transformation (after 21 days post infection) (Calnek, 2001) . Once infection enters the fourth stage, T-cell lymphomas will occur in multiple visceral organs and causes sustaining immunosuppression (Calnek, 1986; Calnek, 2001) . MDV induced T-cell lymphoma is also an excellent biomedical model for the research in virus-induced lymphoma (Calnek, 1986; Burgess et al., 2004 Recently, a novel species of gene regulators, miRNAs, have been reported to be extensively involved in multiple biological processes including development, growth, differentiation, proliferation, apoptosis, and tumorigenesis (Brennecke et al., 2003; Giraldez et al., 2005) . miRNAs are one class of non-coding single strand RNAs with the length of 21 to 26 nucleotides (nt), and negatively regulate gene expression by interfering with posttranscriptional protein translation (Zamore and Haley, 2005; Valencia-Sanchez et al., 2006) . The dysfunction of miRNAs was reported in many types of tumors regardless of the cell type or etiology (Bandres et al., 2009; Garzon et al., 2009; Motoyama et al., 2009; Sun et al., 2009; Ura et al., 2009) , acting as either oncogenes or tumor suppressors (Dalmay, 2008; Gartel and Kandel, 2008) .
Since Burnside et al. (2006) first identified chicken and MDV miRNAs implicated in MDV-infected chicken embryo fibroblasts, there have been many studies which have discovered miRNAs originating from both host and MDV (Burnside et al., 2006; Burnside et al., 2008; Yao et al., 2008; Zhao et al., 2009; Luo et al., 2011; Zhao et al., 2011; Lian et al., 2012; Stik et al., 2013; Li et al., 2014b; Parnas et al., 2014; Chi et al., 2015; Zhao et al., 2015) . Yao et al. (2008) profiled miRNAome of MDV-transformed T-cell line MSB1 and found abundant host miRNAs and novel miRNAs. Tian et al. (2012) utilized microarrays to investigate miRNA expression signatures induced by MDV in 2 highly inbred lines, 6 3 and 7 2 , which are resistant and susceptible, respectively, to MD tumors, and they found that 64 miRNAs had significant differential expression patterns between infected and non-infected line 7 2 at 21 days post injection. In addition to analyzing the repertoire of miRNAs in MDV-infected samples, the functions of some individual miRNAs, including gga-miR-155, ggamiR-26a, gga-miR-221/222, and gga-miR-21, were also further investigated in many research studies. GgamiR-155 was identified to be a functional orthologue of miR-M4 , and could rescue the oncogenic potential of miR-M4-deleted virus (Zhao et al., 2011) . Gga-miR-221/222 could suppress the expression of cell cycle regulatory molecule p27Kip1 in Marek's disease T-cell lymphoma ). GgamiR-26a mediated interleukin-2 (IL2) expression, and downregulation of miR-26a in MD tumor cells facilitated proliferation of transformed cells by relieving the suppressive effect on IL2 . The decrease of gga-miR-26a expression could also result in upregulation of Never In Mitosis Gene A (NIMA)-related kinase 6 (NEK6) which was able to stimulate tumorigenesis in vitro and in vivo (Li et al., 2014a) . Gga-miR-21 has been confirmed to be induced by MDV Eco-Q (Meq) to mediate lymphomagenesis (Stik et al., 2013) .
In our previous study, we profiled miRNA transcriptome in MD lymphoma by Solexa deep sequencing. Some deregulated miRNAs were found, including ggamiR-181a, which was downregulated in MDV infected samples (Lian et al., 2012) . In this study, we further investigated the effect of gga-miR-181a on MSB1 cell proliferation, and verified its target, MYBL1, by Western blot.
MATERIALS AND METHODS

Sample Collection
In our previous study, 150 chickens from a White Leghorn specific pathogen-free line (Lian et al., 2010) were used for MDV challenge trial. Briefly, one hundred were infected intraperitoneally with 2,000 plaque-forming unit of the MDV GA strain and 50 chickens were injected with the same dosage of diluent (0.2 mL) at 1-day-old as controls. The 2 groups were housed in separate isolators in different rooms. The experimental period lasted to 56 days post infection. Animal experiments were approved by the Animal Care and Use Committee of China Agricultural University (Approval ID: XXCB-20090209). Eight MDVinfected tumorous spleens (whole spleens including tumor and adjacent non-tumor tissue), 8 MD lymphomas from livers (dissected from adjacent non-tumor tissue), 8 non-infected spleens, and 8 non-infected livers (Table 1) were collected during 31 to 55 days post infection (Lian et al., 2012) . All tissues were stored in RNAfixer (BioTeke Co., Ltd, Beijing, China) at 4
• C overnight and then transferred to −80
• C until RNA isolation.
Cell Culture and miRNA Transfection
MDV-transformed lymphoid cell line, MSB1, provided by Dr. C. Itakura, was cultured in 6-well plates and grown in RPMI-1640 with 10% fetal bovine serum (Invitrogen, Carlsbad, CA), under 5% CO2 at 37
• C. The gga-miR-181a mimic and negative control at 100 nM (RiboBio Co. Ltd. Guangzhou, China) were transfected into MSB1 cells by using FuGENE R HD (Promega, Madison, WI) according to the manufacturer's instructions. Three biological triplicates were used in each group. Cells were collected for RNA isolation at 24 h, 48 h, and 72 h post transfection.
RNA Isolation and Real-time PCR Analysis
Total RNA was isolated from MSB1 cells by mirVana miRNA Isolation Kit (Ambion, Austin, TX), and was reversely transcribed by gga-miR-181a specific stem-loop-RT primers (Lian et al., 2012) by M-MLV reverse transcriptase (Promega, Madison, WI). Total RNA from tissues was extracted by Trizol reagent (Invitrogen, Carlsbad, CA) and reversely transcribed into cDNA by oligodT primers and M-MLV reverse transcriptase. The qPCR primers specific for MYBL1 were F-5'-TTCAACACCAAGGACACCAA -3', R-5'-CTC-CTGCTTGCAGCTTTTAT -3'. The primers for 28s and gga-miR-181a followed those by Kaiser et al. (2003) and Lian et al. (2012) , respectively. Real-time PCR was performed by ABI 7500 system (Applied Biosystems, Foster City, CA). Each reaction was run in triplicate and in a final volume of 15 μL with 1 μL of cDNA, 100 nM of each gene-specific primer, and 1 × PCR mix (Power SYBR Green PCR Master Mix, Applied Biosystems). The optimum thermal cycling parameters included 95
• C for 10 min, 40 cycles of 95
• C for 15 s, 60
• C for 1 min, 95
• C for 30 s, and 95
• C for 15 s. The relative expression level of gga-miR-181a and MYBL1 was calculated with reference to expression of 28S rRNA, and results were described as fold change determined by 2-ΔΔCt method. The data was expressed as means ± standard error. The data for miRNA expression was subjected to Student t-test, and data for MYBL1 expression among 4 groups was subjected to one-way ANOVA analysis and multiple tests with significant level at a P-value of <0.05.
Western Blot Analysis
Total proteins were isolated from MSB1 cells at 48 h, 72 h, and 96 h post transfection using radioimmunoprecipitation assay buffer supplemented with phenylmethanesulfonyl fluoride (PMSF) (Beyotime, Shanghai, China). Radioimmunoprecipitation assay buffer included 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na 3 VO 4 , and 1 μg/mL leupeptin. Total proteins were measured by the BCA protein assay reagent kit (Beyotime, Shanghai, China). Briefly, 10 μg of total proteins were fractionated on 8% SDS-PAGE gel and then transferred to polyvinylidene fluoride (PVDF) membranes (Beyotime, Shanghai, China) by electrophoresis for 2 h at 80 mA. Membranes were blocked for 1 h and then incubated with the primary antibody, anti-MYBL1 (Cat. No.: GWB-ML238D, GenWay, San Diego, CA), or anti-Actin (Cat. No.: AA128, Beyotime, Shanghai, China) overnight at 4
• C. Subsequently, the membranes were washed and incubated with horseradish peroxidase (HRP)-labeled secondary antibody for 1 h, and then visualized by using an enhanced chemiluminescence system (Beyotime, Shanghai, China). The bands of Western blot were analyzed by ImageJ and transformed into gray scale value.
Cell Proliferation Assay
The MSB1 cells were transfected with gga-miR-181a mimic (100 nM) or negative control (100 nM), respectively. Cell proliferation was detected using cell counting Beyotime, Shanghai, China) at 24 h, 36 h, 48 h, and 60 h post transfection. The experiments were performed in triplicate, and the absorbance at 450 nm and 630 nm were measured using a microplate spectrophotometer. The cell viability was calculated by the following formula: (Absorbance) 450 -(Absorbance) 630 . The data was subjected to Student t-test with significant level at a P-value of <0.05.
RESULTS AND DISCUSSION
Gga-miR-181a Affected MYBL1 Protein Expression
Gga-miR-181a was transfected into MSB1 cells, and the expression of gga-miR-181a showed a trend toward being higher at 24 h, 48 h, and 72 h post transfection (Figure 1) . To further verify the interaction between gga-miR-181a and MYBL1, we detected protein level of MYBL1 after transfecting gga-miR-181a mimic and negative control into MSB1 cells by Western blot (Figure 2A-C) . The bands of Western blot were transformed into gray scale values by densitometric analysis software ImageJ. The ratio of gray values of MYBL1 to Actin expression was shown in Figure 2D -F. The expression of MYBL1 was decreased in gga-miR-181a mimic transfection group compared with negative control group at 96 h post transfection ( Figure 2C, F) .
The Differential Expression of MYBL1 among MDV-Infected Tumorous Spleen, MD Lymphoma, Non-infected Spleen, and Non-infected Liver
We found that mRNA level of MYBL1 was upregulated in MDV-infected tumorous spleen and MD lymphoma than that in non-infected spleen and noninfected liver (Figure 3 ). In our previous study, ggamiR-181a was downregulated in tumorous spleen and MD lymphoma from liver compared with non-infected spleen (Lian et al., 2012) . As a predicted target gene of gga-miR-181a, MYBL1 showed a contrary expression pattern, an elevated expression level in MDV-infected samples, which agreed with the prior report that miRNAs negatively modulated the expression of their target genes (Huang et al., 2007) . MYBL1 belongs to Myb proto-oncogene family conserved in most vertebrates (Sleeman, 1993; Foos et al., 1994) , which includes 3 members: MYBL1 (also known as A-myb), MYBL2 (also known as B-myb), and MYB (also known as c-Myb). All of the 3 genes encode transcription factors that bind to transactivation promoters by recognizing a specific DNA sequence (YAACG/TG) (Biedenkapp et al., 1988) . MYB is a cellular counterpart of v-myb oncogene, carried by Avian Myeloblastosis Virus, which transforms cells of hematopoietic origin in the chicken (Golay et al., 1996) . MYBL1 was highly expressed in Burkitt's lymphoma cells, some chronic lymphocytic leukemia, and a small subset of human neoplastic B-cells (Golay et al., 1996) . MYBL1 was involved in the regulation of proliferation and differentiation of B-cells and transformation of lymphoma cells (Facchinetti et al., 1997) . Amplification of MYBL1 was observed in uterine leiomyoma cells after estrogen stimulation, and the overexpression of MYBL1 facilitated cell proliferation (Swartz et al., 2005) . In this study, MD lymphoma from liver showed highest expression level of MYBL1. This could be explained by its high number of transformed lymphocytes, which was considered as a main characteristic of MD tumor (Witter and Schat, 2003) . Generally, a mixed population of small to large lymphocytes, lymphoblasts, plasma cells, and macrophages could be typically found in MD tumors (Payne et al., 1976) . detected at 24 h, 36 h, 48 h, and 60 h post transfection. The viability of MSB1 cells showed a decrease trend in mimic transfection group than that in negative control at 24 and 36 h post transfection. A significant reduction of cell proliferation in mimic transfection group was observed at 48 h post transfection (Figure 4) . However, at 60 h post transfection, cell proliferation showed no difference between mimic and control groups, which indicated that effect of gga-miR-181a declined at this time point. It was reported that miR-181a was implicated in cellular differentiation and development, immunity, metabolism, tumor suppression, and carcinogenesis (Calin and Croce, 2006; Lashine et al., 2011) . However, it is still controversial that miR-181a functions as a tumor suppressor or an oncomir (Zhu et al., 2013) . In humans, the aberrant expression pattern of miR-181a occurred in many types of tumors. It was reported that miR-181a was upregulated in human breast cancer cells, human gastric cancer, and human colon cancer tissue Jiao et al., 2013; Wei et al., 2014) , but downregulated in most solid tumors such as primary glioblastomas, oral squamous cell carcinoma cells, non-small cell lung, and chronic lymphocytic leukaemia (Ciafre et al., 2005; Marton et al., 2008; Shi et al., 2008; Chen et al., 2010; Gao et al., 2010; Gao et al., 2011; Shin et al., 2011; Zhu et al., 2013) . He et al. (2013) reported that miR-181a suppressed salivary adenoid cystic carcinoma cell proliferation, migration, and invasion in vitro, by targeting Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2), Mitogen-Activated Protein Kinase 1 (MAPK1), and Snail Family Zinc Finger 2 (SNAI2) gene . As for MD, previous studies showed that gga-miR-181a and b were downregulated in MDV-infected spleens of line 7 2 chickens (Tian et al., 2012) , and expression of gga-miR-181b was reduced in splenic tumors infected with MDV-GA strain (Li et al., 2014a) . In agreement with these 2 studies, our previous experiment also found that ggamiR-181a and b were downregulated in MD lymphoma (Lian et al., 2012) . In this study, we observed that ggamiR-181a inhibited MSB1 cell proliferation, which indicated that gga-miR-181a might act as a MD tumor suppressor.
Gga-miR-181a showed An Inhibitory Effect on MSB1 Cell Proliferation
